An announcement from Opthea Limited ( (AU:OPT) ) is now available.
Opthea Limited has announced a new application for the quotation of securities on the Australian Securities Exchange (ASX). The announcement involves the quotation of 896 ordinary fully paid securities, which were issued as a result of options being exercised or other convertible securities being converted. This development is part of Opthea’s ongoing efforts to enhance its financial flexibility and strengthen its market position in the biotechnology sector.
More about Opthea Limited
Opthea Limited is a biotechnology company focused on developing therapies for eye diseases. The company primarily targets the treatment of retinal diseases, aiming to improve vision and quality of life for patients.
YTD Price Performance: 9.09%
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $506.1M
For detailed information about OPT stock, go to TipRanks’ Stock Analysis page.